TROBICIN Drug Patent Profile
✉ Email this page to a colleague
When do Trobicin patents expire, and when can generic versions of Trobicin launch?
Trobicin is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in TROBICIN is spectinomycin hydrochloride. There are four drug master file entries for this compound. Additional details are available on the spectinomycin hydrochloride profile page.
Summary for TROBICIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
Patent Applications: | 4,123 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TROBICIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TROBICIN
US Patents and Regulatory Information for TROBICIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | TROBICIN | spectinomycin hydrochloride | INJECTABLE;INJECTION | 050347-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | TROBICIN | spectinomycin hydrochloride | INJECTABLE;INJECTION | 050347-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |